Remove 2019 Remove FDA Remove Licensing Remove Public Health
article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

Together, these articles underscore the injustice of the present moment and emphasize the need to reform intellectual property protections for government-funded inventions of public health significance. Recent Research on Public Funding of mRNA Technology The first of the two new articles is an in-depth empirical study of U.S.

article thumbnail

CareCloud CEO predicts what's around the corner for telehealth

Healthcare IT News - Telehealth

What's less certain, however, is what that utilization will look like in the future, particularly as the end of the public health emergency looms. We launched our first fully integrated telehealth solution in the 2018-2019 timeframe. CareCloud CEO and President A. Did some specialties see a greater increase in numbers?

COVID-19 182
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Telepsychiatry will continue to grow – and become the house call of yesteryear

Healthcare IT News - Telehealth

Despite the end of the public health emergency, individuals and informed political leaders will continue to work with pharmacies to continue access to vital care for individuals in need of medication for mental health because mental health is part of overall health. Your third prediction concerns medication.

COVID-19 161
article thumbnail

SQA Regulatory Surveillance Summary 2 | Monthly Update 2021

SQA

United States Food and Drug Administration (FDA) – Regulations and Guidances for Biologics and the Bioresearch Monitoring Program (BIMO). Manufacturing Considerations for Licensed and Investigational Cellular and Gene Therapy Products During COVID-19 Public Health Emergency, January 2021.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

China’s drug MAH system has been implemented nationwide since the revised Drug Administration Law came into force in 2019. Of interest is a reference to the FDA’s draft document “Computer Software Assurance for Production and Quality System Software,” which was recently published on 13 September 2022.

article thumbnail

FDA Finalizes Guidance on Combination Products

C&M Health Law

Food & Drug Administration (FDA) published a notice in the Federal Register announcing the availability of a final guidance for industry and FDA staff entitled “Principles of Premarket Pathways for Combination Products”. The final guidance is available on the FDA’s website. On January 31, 2022, the U.S.

FDA 52
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – March And April

SQA

The deadline for reporting serious incidents not constituting serious public health threats, deaths, or unanticipated serious deteriorations in state of health was reduced to 15 calendar days. The name and address of manufacturers provided by the company on its establishment license application were not accurate.

FDA 40